Colitis

The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners

Winners awarded with trip to California to participate in the Foundation's Orange County Take Steps event NEW YORK, June 24 /PRNewswire/ -- The Crohn's & Colitis Foundation, in partnership with Procter & Gamble Pharmaceuticals (P&GP), announces six winners from the seco...

Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients

Ulcerative Colitis "Quick Tips" Contest Winners will be Awarded Travel to CCFA California Event NEW YORK, March 11 /PRNewswire-FirstCall/ -- For ulcerative colitis (UC) patients, managing their everyday life can be a challenge, but with perseverance and experience, many have found ways to hel...

Identification of genetic markers for ulcerative colitis could lead to treatment

This release is available in French . Montreal, January 8, 2009 An international consortium of researchers, including major contribution from a team led by Dr. John D. Rioux, a professor of medicine at the Universit de Montral and the Montreal Heart Institute, has identified genetic marke...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

BASINGSTOKE, UK and PHILADELPHIA, US June 17 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the publication of data from a randomized, long-term safety and tolerability study (study 303) of ulcerative colitis (...

A rare case of ischemic colitis caused by chronic venous insufficiency

Ischemic injury to the bowel is a well known disease entity that has a wide spectrum of pathological and clinical findings. A sudden drop in the colonic blood supply is key to its development. However, chronic venous insufficiency by obstruction of macrovascular mesenteric vein rarely causes isch...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

Authors Conclude Communication and Compliance Important for Addressing Challenges Uncovered in Survey AVENTURA, Fla., Dec. 7 /PRNewswire/ -- Nearly three out of four patients with ulcerative colitis (UC) consider feeling unwell to be a normal part of life, while gastroente...

Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients

OAK BROOK, Ill. November 19, 2007 A pilot study from researchers at Kyushu University in Fukuoka, Japan, found that narrow band imaging (NBI) colonoscopy used in cancer surveillance for ulcerative colitis patients can identify flat dysplastic lesions. The research appears in the November issue ...

IBD Patient Launches iPhone Application to Help Doctors Treat Crohn's and Ulcerative Colitis

Developed by a Crohn's patient with help from GI specialists, GI Monitor, an iPhone App launched by WellApps, Inc., allows patients with (IBD) Crohn's and Ulcerative Colitis to track their symptoms and deliver accurate data to their doctors. UPPER SADDLE RIVER, N.J., May 19 /PRNewswire/ -- We...

Supplement of probiotics provides a new therapy for ulcerative colitis

The animal and clinical studies indicated that gastrointestinal bacteria play an important role in the development of UC, and the supplement of probiotics was beneficial for UC. While Because of the specific damage site of UC and the different colonization of each bacterium, it is suggested that d...

Previously unknown immune cell may help those with Crohn's and colitis

The tonsils and lymphoid tissues in the intestinal tract that help protect the body from external pathogens are the home base of a rare immune cell newly identified by researchers at Washington University School of Medicine in St. Louis. The researchers indicate that the immune cells could have a ...

Colitis in Medical Technology

Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

CHICAGO, June 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Lar...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with Inflammatory Bowel Disease SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the Active Ulcerative Colitis Tri...

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- A post hoc analysis showing time to symptom resolution data from a study (study 302) of Shire plc's (LSE: SHP, Nasdaq: SHPGY) ulcerative colitis (UC) drug, LIALDA(TM), will be presented today at Digestive Disease Week (DDW). Study 302 (further referr...

Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis

Presentation of Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week 2008 PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that it has initiated the Phase 2 clinical development program of MDX-1100, a fully h...

Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis

Findings reinforce the benefits of Asacol for ulcerative colitis patients AVENTURA, Fla., Dec. 5 /PRNewswire/ -- Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an eff...

New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients

Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to be presented tomorrow at the American College of Gastroenterology (ACG) Annual Scientif...

Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis

-- Phase 1 RDEA119 data expected in second half of 2008 -- -- Presentation at the Seventh Annual JMP Securities Research Conference on May 21st canceled; webcast of corporate update scheduled during Ardea's Annual Stockholder Meeting on May 22nd at 9:30 a.m. PT -- SAN DIEGO, May...

Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis

4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy and was well tolerated in ASCEND III study SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, 70 percent ...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life

UC's Overall Psychological Toll Is Greater Than for Asthma, Rheumatoid Arthritis and Migraines WAYNE, Pa., May 17, 2007 /PRNewswire/ -- Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of lif...

Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW

Post-hoc analysis shows nearly nine out of ten patients taking once-daily Lialda remained relapse free at the end of 12 months WASHINGTON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A long-term phase III, open-label 12-14 month extension study (303) presented at the British Society of Gastroente...

More>>

Colitis in Medical Products

Pseudomembranous Colitis Toxin Assay

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Antibiotic-Associated Colitis Toxin Test

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Colitis in Medical Definition

Pathology

...itis - Diverticulitis - Diverticulosis - IBD ( Crohn's , Ulcerative colitis ) - IBS - Constipation - Colorectal cancer - Hirschsprung's - Pseudomembranous colitis Hernia Inguinal - Femoral - Umbilical - Incisional - Di...

Colitis in Medical Dictionary

Colitis

Colitis is a chronic digestive disease characterized by inflammation of the colon. ... Enterohemorrhagic colitis may be caused by Shiga toxin in Shigella dysenteriae ... Outlines the symptoms, diagnostic procedures, and risks and benefits of several drugs and kinds of surgery ...

Ulcerative colitis

Ulcerative colitis is a form of inflammatory bowel disease (IBD). Ulcerative colitis is a form of colitis , a disease of the intestine, specifically the large intestine or colon, that includes characteristic ulcers, or open... Outlines the symptoms, diagnostic procedures, and r...

Ischemic colitis

Ischemic colitis is a medical condition in which inflammation and injury of the large intestine result from inadequate blood supply. Although uncommon in the general population, ischemic colitis occurs with greater frequency... Ischemic colitis — Comprehensive overview cover...

Toxic megacolon

...megacolon n A serious complication of ulcerative colitis that may result in perforation of the ... Toxi... Toxic megacolon is mainly seen in ulcerative colitis and pseudomembranous ... MedlinePlus Encyclopedia... . Crohn's disease - affected areas. Ulcerative colitis ... Toxic megacolon occurs as a complication ...

Remission

... fitness, and lifestyle destination. Type... Information on Ulcerative colitis as a medical condition with Ulcerative colitis ... The goal is to induce remission initially with medications, followed...

Rectum

...ectum , cancer cells are often found in ... Online Medical Dictionary and glossary with medical definitions ... Ulcerative proctitis:Ulcerative colitis that is limited to the rectum . ... ... shows that 39% of colon and rectum cancer cases are diagnosed while the cancer ... cancer of t...

Proctitis

...s is associated with diseases such as ulcerative colitis or Crohn's disease. ... Idiopathic Proctitis ... The cause of colitis and idiopathic proctitis are not known, but f.... Symptoms of Proctitis ... About Ulcerative colitis & Proctitis . How IBD is Diagnosed. Possible ...

Nicotine

...ddictive drugs in the United States. ... Original Article from The New England Journal of Medicine -- Transdermal Nicotine for Active Ulcerative colitis ... and plasma nicotine and cotinine ... A man about to use a piece of nicotine gum. ... The nicotine is delivered to the bloodstream via ...

Ileum

...ty of anti-TNF therapy in the management of Crohn's disease, and discusses ... terminal ileum was characterized ... Introduction to Ulcerative colitis as a medical condition including symptoms, ... affects the small intestine except for the lower section, called the ileum . ... Register today...

Dietary recommendations

...ne in. everyday meal planning. ... Standard Dietary Recommendations . cooking or sauteing (with a small ... Complete information for Ulcerative colitis and standard dietary recommendation such as Vitamins, Minerals, Fish oil, and general advice . Additional view on ... Complete information for...

Colitis in Biological News

Caffeic acid inhibits colitis in a mouse model -- is a drug-metabolizing gene crucial?

This release is available in Chinese . Researchers at Iowa State University have found that increased expression of a form of cytochrome P-450 (CYP4B1) is a key marker of inhibition of colitis in mice by ca...

New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics

PITTSBURGH, Jan. 4 An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative colitis. The findings, which appear today as an advance online publication of the journal Nature Genetics , bring researchers...

Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients

PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of colectomy surgeries for patients with moderately to severely active ulcerative colitis (UC). Accordin...

Antibiotics take toll on beneficial microbes in gut

...gut may influence how inflammatory bowel disease develops and progresses. The study will also inform ongoing research in his lab to gain insights into colitis associated with C. difficile infection. The Young laboratory recently published a study that demonstrates that long-term decreases in gut microbe di...

Enzyme involved in inflammatory bowel disease discovered at Penn State College of Medicine

...he half-a-million Americans affected by ulcerative colitis and Crohn's disease, collectively referred to as I...ssociated with both Crohn's disease and ulcerative colitis with low meprin levels. "This discovery is a m...genetic control of inflammation, and of ulcerative colitis and Crohn's disease in particular," Bond said. She...

Stem cell focus for IBD wound healing

...tural molecules to spark the recovery of patients suffering from ulcerative colitis and Crohn's disease, reducing their risk of associated complications such a...ur growth. Funded with a 118,500 grant from the National Association for colitis and Crohn's Disease (NACC), the two-year project is being led by Professor ...

Unexpected finding opens up new way to stop autoimmune diseases and transplant rejection

...re of the patient's antibodies in the laboratory and gave them to mice with colitis (an autoimmune disorder). After receiving the antibodies, symptoms of colitis were reduced. "This discovery is very good news for people with autoimm...

The quest for specific anti-inflammatory treatment

...on and cancer Inflammatory processes may have various causes, an infection, for example. Chronic inflammatory diseases also exist, such as ulcerous colitis or multiple sclerosis, where, due to a constant state of inflammation, the cells are destabilised, provoking neoplasic processes, i.e. they generate n...

New genes found for inflammatory bowel disease in children

... the medications will be easier to deliver as well as more customized to each patient." The study team also found an association between ulcerative colitis and genes on the major histocompatiblity complex (MHC) on chromosome 6. The MHC is a large group of genes with important roles in the immune system, a...

Weill Cornell science briefs June/July 2008

...use most IBD-sufferers are young teens or in their 20s, and are the most likely patient-group to miss a dose. IBD includes two diseases: ulcerative colitis and Crohn's disease. Both cause inflammation in the gastrointestinal (GI) tract, leading to bloody diarrhea, abdominal pain and weight loss. Drugs to ...

Colitis in Biological Technology

The Crohn's & Colitis Foundation of America and Shire Launch Virtual 'IBD March on the Hill' to Increase Funding for Digestive Disease Research

Virtual March Connects 'IBD Day on the Hill' Advocates in Washington, D.C. with Online Supporters PHILADELPHIA, May 6 /PRNewswire-FirstCall/ -- Today the Crohn's & Colitis Foundation of America (CCFA) and Shire plc (LSE: SHP, Nasdaq: SHPGY ) joined forces to launch the first-ever virt...

Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis

As Part of "In the Zone for UC" Campaign, Centocor Ortho Biotech Inc. Will Donate $5,000 to the Crohn's & Colitis Foundation of America for Each Point Pisani Scores During 2008-2009 Season HORSHAM, Pa., March 2 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today a partnership wit...

Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis

Forms One of the Largest Sales Teams Promoting a 5-ASA Medicine BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today a co-promotion agreement with TAP Pharmaceutical Pr...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... months to June 30, 2009 (2008: 27.6%). LIALDA/MEZAVANT - Ulcerative colitis Product sales of LIALDA/MEZAVANT for the three months to June 30, 20...sion of pricing and reimbursement negotiations. PENTASA - Ulcerative colitis Sales of PENTASA(R) for the three months to June 30, 2009 were $54.0...

Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO

...pment candidates include TRIOLEX(R) (HE3286), a next-generation compound currently in clinical trials for the treatment of type 2 diabetes, ulcerative colitis and rheumatoid arthritis, and APOPTONE(R) (HE3235), a next-generation compound in a clinical trial for the treatment of late-stage prostate cancer. F...

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

... in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commerciali...

ViroPharma to Present at Two June Healthcare Conferences

... in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commerciali...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

...ve tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD. In preclinical studies, the compound worked both therapeutically and prophylactically in models of Crohn's disease ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commerciali...

Shire begins the year with a strong performance

...NT(R) (mesalamine) for the treatment of ulcerative colitis in certain EU countries during 2009; - ...(2008: 26.1%). LIALDA/MEZAVANT - Ulcerative colitis Product sales of LIALDA/MEZAVANT for the th...ursement negotiations. PENTASA - Ulcerative colitis Sales of PENTASA for the three months to Ma...